We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Circio Holding Asa | LSE:0RIS | London | Ordinary Share | NO0013033795 | CIRCIO HOLDING ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 15.98 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Home Health Care Services | 10M | -432.9M | -2.2969 | -6.96 | 3.01B |
From Apr 2019 to Apr 2024
OSLO, Norway, Dec. 12, 2018 /PRNewswire/ --
Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that CEO Øystein Soug presented today at DNB 9th Annual Nordic Healthcare Conference in Oslo, Norway.
The presentation provided a corporate overview, highlighting the Company's two platform technologies including clinical data from its lead pipeline asset, ONCOS-102, an oncolytic adenovirus, and the TG cancer vaccine program that targets tumors that express mutated forms of RAS - mutations known to drive cancer.
Please see the presentation attached. TRVX DNB presentation
The presentation is also available to download at www.targovax.com.
CONTACT:
For further information, please contact:
Renate Birkeli, Investor Relations
Phone: +47-922-61-624
Email: renate.birkeli@targovax.com
Media and IR enquires:
Andreas Tinglum - Corporate Communications (Norway)
Phone: +47-9300-1773
Email: andreas.tinglum@corpcom.no
Simon Conway/Stephanie Cuthbert - FTI Consulting (International)
Phone: +44-20-3727-1000
Email: Targovax@fticonsulting.com
This information was brought to you by Cision http://news.cision.com
http://news.cision.com/targovax/r/targovax-presents-at-dnb-9th-annual-nordic-healthcare-conference,c2698730
The following files are available for download:
https://mb.cision.com/Public/17093/2698730/b5e0270377c81c80.pdf | TRVX DNB presentation |
Copyright 2018 PR Newswire
1 Year Circio Holding Asa Chart |
1 Month Circio Holding Asa Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
